The Houliares Family Takes on CMT6

by | Mar 6, 2023 | 0 comments

Houliares family picture CMTWe have two choices in this world. We can sit back and do nothing, allowing this disease to happen, or we can go out and fight to make a difference.

When Zach was first diagnosed with CMT6 after 14 years of doctors trying to figure it out, we were fighting mad that there was a disease out there that no one has ever heard of. How can this be? After researching on the internet, which didn’t provide a lot of information, my first call was to the HNF, and I spoke with Allison Moore. She was the very first person that was able to answer so many questions about CMT that all the doctors could not.

Zach’s form of CMT is different, though. He is legally blind, with a vision of 20/400. With a rare form of a rare disease, our new mission in life became raising awareness and money for research for Zach and others like him. There could be many other people who are not even diagnosed because doctors are not aware of what CMT6 is. So we are taking matters into our own hands and spreading the word.

Zach loves to play sports but can’t physically play on any school teams due to his blindness and difficulty walking. But one week after this diagnosis, Zach was unexpectedly sent onto the basketball court in a game with a minute left. Unscripted and unrehearsed, his teammate threw him the ball and swish, all net. There wasn’t a dry eye in the house. The video played on the local news and even ESPN.

That was only the beginning. We started raising awareness in Zach’s schools by selling ”Find a Cure for CMT” bracelets. Most local business where we live in Victor, NY have a jean day where if employees pay $1, they can wear jeans to work with proceeds going to HNF “Team Zach.” Within 10 months of Zach’s diagnosis we had a successful fundraising event at my husband’s workplace and raised quite a bit of money. We already have a motorcycle/vehicle scavenger hunt event planned for July of this year and a second event is in the works. People are willing to support a good cause, and it’s our job to make these events happen, no matter how big or small. Everyone sees and know the symbols like the pink ribbons for breast cancer, puzzle piece for autism. Inherited neuropathies are just as big and as powerful. Fighting to raise awareness for CMT has to start somewhere, so why can’t it start with us. Never give up hope. Learn more about Zach’s Team.

Learn more on this topic

Related Blog Posts

Do You Have Charcot-Marie-Tooth Type 4 (CMT4)? – We Need Your Help

Autosomal recessive demyelinating CMT4 patients present with earlyonset and slowly progressing symptoms. These include progressive distally accentuated weakness and atrophy of muscles in the lower limbs. In addition, patients may have weakness and atrophy of hands, sensory loss and pes cavus (high-arched feet), and walking difficulties. Further information on CMT4 can be found at Orphanet.

Hot Off the Press – Potential Treatment for CMT1A

Two recent publications from Pharnext describe a novel synergistic combination of 3 drugs (baclofen, naltrexone and sorbitol) and its effect on CMT1A both in the lab and in a phase II clinical trial. These 3 drugs already approved but for unrelated conditions, are combined at new optimal lower doses and under a new formulation. This novel potential therapeutic is called PXT-3003.

Support CMT Therapeutic Alliance

HNF has entered into a joint venture – the CMT Therapeutic Alliance – with a unique non profit organization (BioPontis Alliance for Rare Diseases) that brings professional drug discovery capabilities to translate our research results into potential treatments.

Scientific Advisory Board Meeting

Scientific Advisory Board Meeting

On the 7th of November we convened our scientific advisory board meeting at the HNF offices in NY. We have written a detailed review that has been published and captures all of the discussion and make this freely available to the scientific community.

Breaking News: First Therapeutic Gene Therapy to Treat an Inherited Neuropathy is Approved for Clinical Trial!

The first disease community to receive a therapeutic gene to the spinal cord for an ultra rare inherited neuropathy is Giant Axonal Neuropathy (GAN). Congratulations to Hannah’s Hope Fund (HHF), a 501(c)3 public charity, which has driven this collaborative research in less than six years. Six million dollars has been raised to date to fund pre-clinical and clinical research on this rare disease.

A Rare Disease Patient That Does It All!

A movie script could not play out like this. There are very few occasions when a rare disease patient becomes the topic of a story that is truly uplifting. Often the stories are tragic or disheartening. That was not the case, however, with CMT patient Kim Goodsell.

Hot Off the Press

One of the ways that some CMT patients first become aware of their disease is when they are given a drug treatment for another disease. This is termed chemotherapy-induced neurotoxicity. Drugs such as paclitaxel and the vinca alkaloids that are widely used in cancer treatment cause severe peripheral neuropathy and in some patients this exacerbates CMT, revealing it perhaps for the first time.

Kara Q&A: How to “support” a friend or family member that’s affected with Charcot-MarieTooth.

My name is Courtney Hollett, Fundraising Coordinator at the Hereditary Neuropathy Foundation. This time of year I count my blessing daily and wanted to share with you a Q&A session I had with a new supporter of HNF. Kara, like myself has many family members affected with CMT and I reached out to her to share her thoughts and advice about how to “support” a friend or family member that’s affected with Charcot-MarieTooth.

Join the conversation

Leave a Comment

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news